Does METYRAPONE Cause Product use in unapproved indication? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product use in unapproved indication have been filed in association with METYRAPONE (Metopirone). This represents 2.9% of all adverse event reports for METYRAPONE.
16
Reports of Product use in unapproved indication with METYRAPONE
2.9%
of all METYRAPONE reports
4
Deaths
9
Hospitalizations
How Dangerous Is Product use in unapproved indication From METYRAPONE?
Of the 16 reports, 4 (25.0%) resulted in death, 9 (56.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METYRAPONE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does METYRAPONE Cause?
Off label use (277)
Nausea (53)
Drug ineffective (39)
Pneumocystis jirovecii pneumonia (31)
Fatigue (30)
Vomiting (27)
Dizziness (26)
Adrenal insufficiency (23)
Anaemia (23)
Exposure during pregnancy (22)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which METYRAPONE Alternatives Have Lower Product use in unapproved indication Risk?
METYRAPONE vs MEXILETINE
METYRAPONE vs MIANSERIN
METYRAPONE vs MICAFUNGIN
METYRAPONE vs MICARDIS
METYRAPONE vs MICONAZOLE